Povorcitinib, Placebo, Povorcitinib, Povorcitinib
INCB 54707-208
Phase 2 small_molecule active
Quick answer
Povorcitinib, Placebo, Povorcitinib, Povorcitinib for Treatment of patients with inadequately controlled moderate to severe asthma is a Phase 2 program (small_molecule) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte Biosciences Distribution B.V.
- Indication
- Treatment of patients with inadequately controlled moderate to severe asthma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active